Category Archives: – Policy

FDA CDER Director on Benlysta for lupus and adaptive clinical trials.

July 27, 2011- Janet Woodcock, MD, Director of the FDAs new drug division, CDER, discusses with Steven Greer,

Posted in - Biotech, - Pharma, FDA, Rheumatology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer,

Posted in - Biotech, - Generics, FDA | Leave a comment

WABC radio morning show Bernie & Sid interviews Steven E. Greer, MD: May 21, 2020

May 21, 2020- by Steven E. Greer, MD In this segment,

Posted in - Opinion, - Pharma, - Policy, Emergency medicine, Infectious disease, Internal Medicine, Pulmonology | Leave a comment

Tony’s Virus

October 15, 2020- by Steven E. Greer, MD

Posted in - Opinion, - Pharma, - Policy, - Reviews, books, devices, Emergency medicine, Infectious disease | Leave a comment

I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show

March 23, 2020- I updated Joe Piscopo today, focusing on the new drugs to treat coronavirus.

Posted in - Opinion, - Policy, CDC, Congress, Emergency medicine, Infectious disease, NIH | Leave a comment

New treatment paradigm for C. Diff colitis

March 31, 2010- Produced and interviewed by Steven E. Greer, MD New drugs

Posted in CDC, Gastroenterology and liver, General surgery, Infectious disease, Michigan, Primary care medicine | Leave a comment

Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs

October 24, 2010- Gordon Guyatt, MD, epidemiologist, internist, and biostatistician at McMaster

Posted in Cardiology, FDA, McMaster University | Leave a comment

Why are suicide rates increasing along with increased usage of antidepressants?

June 8, 2018- Fox News’ Tucker Carlson interviewed author Johan Hari about his book Lost Connections and the

Posted in - Pharma, - Policy, CDC, FDA, Neurology, Primary care medicine, Psychology Psychiatry | Leave a comment

Senator Angus King discusses his bill to make medical device pricing transparent to the public

July 9, 2014- Interviewed by Steven E. Greer, MD Senator Angus King from Maine has proposed a a bill that would make the pricing of medical devices

Posted in - Medical Devices, - Policy, Congress | Leave a comment

The truly scary consequence of this “pandemic” is the erosion of our civil rights

Update May 18, 2023- Three years too late, the cowardly Supreme Court pretends it was outraged all along. The Court issued a decision authored by Justice Gorsuch. In the case of Arizona, et al. v. Alejandro Mayrokas, et al, the … Continue reading

Posted in - Opinion, - Policy, Congress | Leave a comment

COVID mRNA gene therapies never worked and are now clearly harmful

November 5, 2021- by Steven E. Greer, MD In the most prestigious journal in all of science, Science magazine posted this article. The authors studied vaccine efficacy over time in VA patients. The effectiveness at preventing COVID infections fell to … Continue reading

Posted in - Biotech, - Opinion, - Pharma, - Policy | Leave a comment

Early stoppage of clinical trials

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment

Gordon Guyatt, MD: on the problem of early stoppage of clinical trials

January 7, 2009- The ARBITER 6-HALTS study investigating Zetia and Niaspan was stopped

Posted in Cardiology, FDA, McMaster University | Leave a comment

Bobby Kennedy Jr. explains how Tony Fauci killed 300,000 AIDS patients

January 12, 2022- RFK Jr. explains how Tony Fauci killed 300,000 AIDS patients by refusing to approve

Posted in - Opinion, Congress, FDA, Infectious disease, NIH | Leave a comment

WLIR’s Frank Morano interviews Steven E. Greer, MD about The Wuhan virus and herd immunity: 8-3-2020

August 3, 2020

Posted in - Policy | Leave a comment

The Medicaid Roundtable

Part 1: Medicaid primer Part 2: State spending on Medicaid

Posted in CMS | Leave a comment

The Deans of Johns Hopkins and Miami discuss ACO’s

February 28, 2011- By Steven E Greer, MD Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations,

Posted in - Policy, CMS, Johns Hopkins | Leave a comment

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine,  Brigham

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

Alex Berenson sues Biden, the Pfizer CEO, Scott Gottlieb, and others

May 15, 2023-

Posted in - Pharma, - Policy | Leave a comment

Daily aspirin once again proves to be of no use and also deadly

Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin. 

Posted in - JAMA, - Pharma, - Policy, Cardiac surgery, Cardiology, Gastroenterology and liver, General surgery, Neurology, Neurosurgery, Oncology, Primary care medicine | Leave a comment